Blog tagged as immunotherapy

Overview

This patent describes a pharmacological approach using orally administered low-dose type I and type III interferons to reduce muscle injury and stabilize skeletal muscle. Filed in July 2014 and granted in May 2017, the application—by inventors based in Edmond, OK—discloses compositions (incl...